Panel talk about Inify’s third quarter 2023

Inify's Q3 report is published and highlights continuous diagnostic operation and very positive feedback from customers. Inify's CEO Fredrik Palm and Chief Medical Officer Claes Lindh talks about what this means for patients in practice in this panel talk together with Ole Eikeland.
Read More

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 16, 2023. A total of 34,075,774 shares were represented at the Annual General Meeting, corresponding to 75.3% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main decisions made, for further details please refer to the notice available on the company's website.
Read More